Literature DB >> 18583907

Intracoronary delivery of bone marrow cells to the acutely infarcted myocardium. Optimization of the delivery technique.

Jaroslav Meluzín1, Michal Vlasín, Ladislav Groch, Jirí Mayer, Leos Kren, Petr Rauser, Boris Tichý, Ivan Hornácek, Jan Sitar, Stanislav Palsa, Martin Klabusay, Zdenek Korístek, Michael Doubek, Sárka Pospísilová, Leona Lexmaulová, Ladislav Dusek.   

Abstract

OBJECTIVES: Intracoronary cell transplantation during catheter balloon inflations may be associated with adverse events. We studied the effectiveness of an alternative transplantation technique--intracoronary cell infusion.
METHODS: Fourteen pigs, which had survived acute myocardial infarction, were randomized into 2 treatment groups and 2 controls. Three days after infarction, 12 pigs underwent allogeneic intracoronary mononuclear bone marrow cell transplantation using either the standard technique (short-term cell injections during repeat balloon inflations, technique A, n = 6) or continuous intracoronary cell infusion without balloon inflations (technique B, n = 6). Implanted cells were stained with fluorescent dye. After transplantation, the pigs were euthanized and myocardial samples were analyzed by fluorescent microscopy.
RESULTS: The mean numbers of fluorescently labeled bone marrow cells in the infarction border zone, in the infarction mid-area and in the center of myocardial infarction were 84, 72 and 55 using technique A, and 29, 57 and 46 using technique B, respectively. The mean cell retention in the infarction border zone of 84 cells for technique A and 29 cells for technique B differed significantly (p = 0.034, two-tailed t test).
CONCLUSION: The continuous intracoronary cell infusion technique is a less efficient cell delivery technique as compared with the standard technique using repeat intracoronary balloon inflations. (c) 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18583907     DOI: 10.1159/000141462

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  5 in total

Review 1.  Delivery of gene and cellular therapies for heart disease.

Authors:  Justin A Mariani; David M Kaye
Journal:  J Cardiovasc Transl Res       Date:  2010-05-11       Impact factor: 4.132

2.  In vivo functional and transcriptional profiling of bone marrow stem cells after transplantation into ischemic myocardium.

Authors:  Ahmad Y Sheikh; Bruno C Huber; Kazim H Narsinh; Joshua M Spin; Koen van der Bogt; Patricia E de Almeida; Katherine J Ransohoff; Daniel L Kraft; Giovanni Fajardo; Diego Ardigo; Julia Ransohoff; Daniel Bernstein; Michael P Fischbein; Robert C Robbins; Joseph C Wu
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-10-27       Impact factor: 8.311

3.  Results of a phase 1, randomized, double-blind, placebo-controlled trial of bone marrow mononuclear stem cell administration in patients following ST-elevation myocardial infarction.

Authors:  Jay H Traverse; David H McKenna; Karen Harvey; Beth C Jorgenso; Rachel E Olson; Nancy Bostrom; Diane Kadidlo; John R Lesser; Vikrant Jagadeesan; Ross Garberich; Timothy D Henry
Journal:  Am Heart J       Date:  2010-09       Impact factor: 4.749

4.  Effect of the stop-flow technique on cardiac retention of c-kit positive human cardiac stem cells after intracoronary infusion in a porcine model of chronic ischemic cardiomyopathy.

Authors:  Matthew C L Keith; Yukichi Tokita; Xian-Liang Tang; Shahab Ghafghazi; Joseph B Moore; Kyung U Hong; Julius B Elmore; Alok R Amraotkar; Haixun Guo; Brian L Ganzel; Kendra J Grubb; Michael P Flaherty; Bathri N Vajravelu; Marcin Wysoczynski; Roberto Bolli
Journal:  Basic Res Cardiol       Date:  2015-07-07       Impact factor: 17.165

5.  Rational transplant timing and dose of mesenchymal stromal cells in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials.

Authors:  Zi Wang; Lingling Wang; Xuan Su; Jun Pu; Meng Jiang; Ben He
Journal:  Stem Cell Res Ther       Date:  2017-01-28       Impact factor: 6.832

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.